Logo

Sagres, Genome Institute of Singapore in Cancer Research Collaboration

Sep 16, 2003

NEW YORK, Sept. 16 (GenomeWeb News) - Sagres Discovery today said it has signed a cancer research collaboration with the Genome Institute of Singapore (GIS).

GIS will use gene-expression profiling and bioinformatics to characterize a collection of Sagres' proprietary provirus-tagged mouse tumors. GIS and Sagres said they would compare the gene-expression data with expression profiles of human cancers in order to map the genetic interaction pathways of the Oncogenome - a list of cancer-causing genes that Sagres has identified.

Sagres said it would have the option to obtain from GIS exclusive rights to novel genes and pathways identified during the collaboration, with commercial terms to be agreed separately. GIS will retain the right to use the results for its non-commercial research and development.

Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.